Cargando…

The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model

AIM: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative...

Descripción completa

Detalles Bibliográficos
Autores principales: Ventelou, Bruno, Arrighi, Yves, Greener, Robert, Lamontagne, Erik, Carrieri, Patrizia, Moatti, Jean-Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325986/
https://www.ncbi.nlm.nih.gov/pubmed/22514619
http://dx.doi.org/10.1371/journal.pone.0034101
_version_ 1782229483935236096
author Ventelou, Bruno
Arrighi, Yves
Greener, Robert
Lamontagne, Erik
Carrieri, Patrizia
Moatti, Jean-Paul
author_facet Ventelou, Bruno
Arrighi, Yves
Greener, Robert
Lamontagne, Erik
Carrieri, Patrizia
Moatti, Jean-Paul
author_sort Ventelou, Bruno
collection PubMed
description AIM: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative scenarios for the macroeconomic performance of countries. METHODS: We used a micro-simulation model based on individuals aged 15–49 selected from nationally representative surveys (DHS for Cameroon, Tanzania and Swaziland) to compare alternative scenarios : 1-freezing of ART programs to current levels of access, 2- universal access (scaling up to 100% coverage by 2015, with two variants defining ART eligibility according to previous or current WHO guidelines). We introduced an “artificial” ageing process by programming methods. Individuals could evolve through different health states: HIV negative, HIV positive (with different stages of the syndrome). Scenarios of ART procurement determine this dynamics. The macroeconomic impact is obtained using sample weights that take into account the resulting age-structure of the population in each scenario and modeling of the consequences on total growth of the economy. RESULTS: Increased levels of ART coverage result in decreasing HIV incidence and related mortality. Universal access to ART has a positive impact on workers' productivity; the evaluations performed for Swaziland and Cameroon show that universal access would imply net cost-savings at the scale of the society, when the full macroeconomic consequences are introduced in the calculations. In Tanzania, ART access programs imply a net cost for the economy, but 70% of costs are covered by GDP gains at the 2034 horizon, even in the extended coverage option promoted by WHO guidelines initiating ART at levels of 350 cc/mm(3) CD4 cell counts. CONCLUSION: Universal Access ART scaling-up strategies, which are more costly in the short term, remain the best economic choice in the long term. Renouncing or significantly delaying the achievement of this goal, due to “legitimate” short term budgetary constraints would be a misguided choice.
format Online
Article
Text
id pubmed-3325986
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-33259862012-04-18 The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model Ventelou, Bruno Arrighi, Yves Greener, Robert Lamontagne, Erik Carrieri, Patrizia Moatti, Jean-Paul PLoS One Research Article AIM: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative scenarios for the macroeconomic performance of countries. METHODS: We used a micro-simulation model based on individuals aged 15–49 selected from nationally representative surveys (DHS for Cameroon, Tanzania and Swaziland) to compare alternative scenarios : 1-freezing of ART programs to current levels of access, 2- universal access (scaling up to 100% coverage by 2015, with two variants defining ART eligibility according to previous or current WHO guidelines). We introduced an “artificial” ageing process by programming methods. Individuals could evolve through different health states: HIV negative, HIV positive (with different stages of the syndrome). Scenarios of ART procurement determine this dynamics. The macroeconomic impact is obtained using sample weights that take into account the resulting age-structure of the population in each scenario and modeling of the consequences on total growth of the economy. RESULTS: Increased levels of ART coverage result in decreasing HIV incidence and related mortality. Universal access to ART has a positive impact on workers' productivity; the evaluations performed for Swaziland and Cameroon show that universal access would imply net cost-savings at the scale of the society, when the full macroeconomic consequences are introduced in the calculations. In Tanzania, ART access programs imply a net cost for the economy, but 70% of costs are covered by GDP gains at the 2034 horizon, even in the extended coverage option promoted by WHO guidelines initiating ART at levels of 350 cc/mm(3) CD4 cell counts. CONCLUSION: Universal Access ART scaling-up strategies, which are more costly in the short term, remain the best economic choice in the long term. Renouncing or significantly delaying the achievement of this goal, due to “legitimate” short term budgetary constraints would be a misguided choice. Public Library of Science 2012-04-13 /pmc/articles/PMC3325986/ /pubmed/22514619 http://dx.doi.org/10.1371/journal.pone.0034101 Text en Ventelou et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Ventelou, Bruno
Arrighi, Yves
Greener, Robert
Lamontagne, Erik
Carrieri, Patrizia
Moatti, Jean-Paul
The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model
title The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model
title_full The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model
title_fullStr The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model
title_full_unstemmed The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model
title_short The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model
title_sort macroeconomic consequences of renouncing to universal access to antiretroviral treatment for hiv in africa: a micro-simulation model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325986/
https://www.ncbi.nlm.nih.gov/pubmed/22514619
http://dx.doi.org/10.1371/journal.pone.0034101
work_keys_str_mv AT venteloubruno themacroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT arrighiyves themacroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT greenerrobert themacroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT lamontagneerik themacroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT carrieripatrizia themacroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT moattijeanpaul themacroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT venteloubruno macroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT arrighiyves macroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT greenerrobert macroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT lamontagneerik macroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT carrieripatrizia macroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel
AT moattijeanpaul macroeconomicconsequencesofrenouncingtouniversalaccesstoantiretroviraltreatmentforhivinafricaamicrosimulationmodel